These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21742588)

  • 21. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluoroquinolones: how to use (but not overuse) these antibiotics.
    Sable CA; Scheld WM
    Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline.
    Anthony KB; Fishman NO; Linkin DR; Gasink LB; Edelstein PH; Lautenbach E
    Clin Infect Dis; 2008 Feb; 46(4):567-70. PubMed ID: 18199038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of recurrent urosepsis with tigecycline: a pharmacological perspective.
    Curcio D
    J Clin Microbiol; 2008 May; 46(5):1892-3. PubMed ID: 18460636
    [No Abstract]   [Full Text] [Related]  

  • 25. Advantage and limitations of nitrofurantoin in multi-drug resistant Indian scenario.
    Shakti L; Veeraraghavan B
    Indian J Med Microbiol; 2015; 33(4):477-81. PubMed ID: 26470951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment with tigecycline of two patients with complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Geerlings SE; van Donselaar-van der Pant KA; Keur I
    J Antimicrob Chemother; 2010 Sep; 65(9):2048-9. PubMed ID: 20554566
    [No Abstract]   [Full Text] [Related]  

  • 27. [Rational antimicrobial therapy of chronic bacterial prostatitis].
    Popov SV
    Antibiot Khimioter; 2013; 58(5-6):32-7. PubMed ID: 24757823
    [No Abstract]   [Full Text] [Related]  

  • 28. Combination of Tigecycline and Levofloxacin for Successful Treatment of Nosocomial Pneumonia Caused by New Delhi Metallo-β-Lactamase-1-Producing Raoultella planticola.
    Pan Z; Liu R; Zhang P; Zhou H; Fu Y; Zhou J
    Microb Drug Resist; 2017 Jan; 23(1):127-131. PubMed ID: 27754764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of broad-spectrum antibiotics and diagnostic problems in urinary tract infections.
    Bergan T
    Arch Intern Med; 1982 Oct; 142(11):1993-9. PubMed ID: 6922692
    [No Abstract]   [Full Text] [Related]  

  • 30. Sisomicin in urinary tract infection: Tolerance and efficacy study.
    Etra W; Surgalla M; Wajsman Z; Baumgartner G; Merrin C
    Urology; 1976 Feb; 7(2):160-4. PubMed ID: 1246785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reply to Davido and Dinh.
    Grayson ML; Macesic N; Trevillyan J
    Clin Infect Dis; 2016 Mar; 62(5):672. PubMed ID: 26689958
    [No Abstract]   [Full Text] [Related]  

  • 32. [Chemotherapy of bacterial infectious diseases of the kidneys and urinary tract].
    Chernomordik AB
    Klin Med (Mosk); 1973 Oct; 51(10):50-4. PubMed ID: 4787279
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical evaluation of guidelines and therapeutic approaches in multi drug-resistant urinary tract infections.
    Concia E; Bragantini D; Mazzaferri F
    J Chemother; 2017 Dec; 29(sup1):19-28. PubMed ID: 29271735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 35. Predicting Antibiotic Resistance in Urinary Tract Infection Patients with Prior Urine Cultures.
    Dickstein Y; Geffen Y; Andreassen S; Leibovici L; Paul M
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4717-21. PubMed ID: 27216064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
    Demonchy E; Courjon J; Ughetto E; Durand M; Risso K; Garraffo R; Roger PM
    Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?
    Gentile I; Maraolo AE; Borgia G
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):875-8. PubMed ID: 27599088
    [No Abstract]   [Full Text] [Related]  

  • 38. Raoultella planticola chronic bacterial prostatitis with prostatic calcifications: successful treatment with prolonged fosfomycin therapy.
    Gian J; Cunha BA
    Int J Antimicrob Agents; 2016 May; 47(5):414. PubMed ID: 27085452
    [No Abstract]   [Full Text] [Related]  

  • 39. [Rimactan. Experimental studies and clinical experience].
    Meyer-Rohn J; Lautenschlager HJ
    Munch Med Wochenschr; 1969 Aug; 111(33):1646-50. PubMed ID: 5395306
    [No Abstract]   [Full Text] [Related]  

  • 40. Repurposing Zidovudine in combination with Tigecycline for treating carbapenem-resistant Enterobacteriaceae infections.
    Ng SMS; Sioson JSP; Yap JM; Ng FM; Ching HSV; Teo JWP; Jureen R; Hill J; Chia CSB
    Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):141-148. PubMed ID: 29019016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.